Meiji Yasuda Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Sell
5,395
-151
-3% -$56K 0.09% 218
2026
Q1
$1.62M Sell
5,546
-458
-8% -$151K 0.08% 236
2025
Q4
$2.1M Buy
6,004
+3,562
+146% +$1.2M 0.1% 211
2025
Q3
$789K Buy
2,442
+51
+2% +$15.9K 0.04% 280
2025
Q2
$930K Sell
2,391
-1,804
-43% -$726K 0.05% 264
2025
Q1
$1.82M Sell
4,195
-85
-2% -$34.1K 0.07% 243
2024
Q4
$1.58M Sell
4,280
-39
-0.9% -$16.3K 0.06% 254
2024
Q3
$2.25M Buy
4,319
+9
+0.2% +$4.81K 0.09% 220
2024
Q2
$2.34M Buy
4,310
+771
+22% +$408K 0.1% 203
2024
Q1
$1.84M Sell
3,539
-597
-14% -$297K 0.08% 232
2023
Q4
$1.95M Sell
4,136
-121
-3% -$56K 0.09% 234
2023
Q3
$1.85M Buy
4,257
+1,337
+46% +$606K 0.09% 241
2023
Q2
$1.3M Sell
2,920
-80
-3% -$36.9K 0.06% 259
2023
Q1
$1.38M Sell
3,000
-1,248
-29% -$594K 0.07% 248
2022
Q4
$2.18M Buy
4,248
+1,432
+51% +$727K 0.1% 230
2022
Q3
$1.28M Sell
2,816
-413
-13% -$198K 0.07% 276
2022
Q2
$1.56M Buy
3,229
+355
+12% +$176K 0.09% 251
2022
Q1
$1.41M Sell
2,874
-320
-10% -$146K 0.08% 265
2021
Q4
$1.48M Sell
3,194
-3,333
-51% -$1.4M 0.09% 210
2021
Q3
$2.43M Sell
6,527
-167
-2% -$63.5K 0.17% 137
2021
Q2
$2.56M Sell
6,694
-250
-4% -$95.5K 0.12% 145
2021
Q1
$2.49M Buy
6,944
+1,149
+20% +$369K 0.18% 136
2020
Q4
$1.86M Sell
5,795
-251
-4% -$77K 0.18% 139
2020
Q3
$1.62M Sell
6,046
-2,000
-25% -$538K 0.18% 138
2020
Q2
$2.12M Buy
8,046
+5,110
+174% +$1.36M 0.2% 124
2020
Q1
$667K Sell
2,936
-6,733
-70% -$1.83M 0.13% 144
2019
Q4
$2.92M Sell
9,669
-1,800
-16% -$495K 0.25% 116
2019
Q3
$2.75M Sell
11,469
-383
-3% -$105K 0.22% 125
2019
Q2
$3.35M Buy
11,852
+700
+6% +$191K 0.28% 97
2019
Q1
$3.2M Sell
11,152
-230
-2% -$66.5K 0.27% 97
2018
Q4
$2.99M Buy
11,382
+910
+9% +$250K 0.28% 99
2018
Q3
$2.87M Buy
10,472
+110
+1% +$28.6K 0.23% 112
2018
Q2
$2.47M Buy
10,362
+190
+2% +$44K 0.22% 122
2018
Q1
$2.23M Buy
10,172
+310
+3% +$72.8K 0.21% 126
2017
Q4
$2.22M Sell
9,862
-1,090
-10% -$232K 0.21% 129
2017
Q3
$2.08M Sell
10,952
-100
-0.9% -$19K 0.2% 132
2017
Q2
$2.08M Buy
11,052
+1,030
+10% +$185K 0.21% 126
2017
Q1
$1.66M Sell
10,022
-1,000
-9% -$159K 0.18% 147
2016
Q4
$1.58M Buy
11,022
+130
+1% +$17.4K 0.18% 153
2016
Q3
$1.36M Buy
10,892
+2,430
+29% +$314K 0.16% 166
2016
Q2
$1.11M Buy
8,462
+4,340
+105% +$594K 0.16% 159
2016
Q1
$573K Buy
4,122
+90
+2% +$12K 0.13% 161
2015
Q4
$562K Sell
4,032
-710
-15% -$97.8K 0.13% 165
2015
Q3
$664K Buy
4,742
+60
+1% +$9.02K 0.16% 145
2015
Q2
$769K Buy
4,682
+420
+10% +$67.1K 0.18% 133
2015
Q1
$658K Buy
4,262
+480
+13% +$68.3K 0.16% 148
2014
Q4
$475K Sell
3,782
-80
-2% -$9.88K 0.11% 198
2014
Q3
$462K Sell
3,862
-120
-3% -$13.8K 0.11% 207
2014
Q2
$429K Buy
+3,982
New +$410K 0.09% 218
2014
Q1
Sell
-4,922
Closed -$455K 347
2013
Q4
$455K Sell
4,922
-2,910
-37% -$259K 0.1% 195
2013
Q3
$655K Buy
7,832
+2,550
+48% +$219K 0.15% 149
2013
Q2
$432K Buy
+5,282
New +$395K 0.1% 188

Other funds holding ELV

Meiji Yasuda Asset Management's ELV Position: Q2 2026 in Review

Meiji Yasuda Asset Management reduced its Elevance Health (ELV) stake by 2.7% in Q2 2026, selling an estimated $56K and leaving 5,395 shares worth $2.09M. The position accounts for 0.09% of the portfolio, ranked #218.

Meiji Yasuda Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.35M in Q2 2019. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Meiji Yasuda Asset Management held 5,395 shares of Elevance Health worth $2.09M as of Q2 2026.
  • Meiji Yasuda Asset Management sold 151 Elevance Health shares in Q2 2026, an estimated $56K.
  • Elevance Health made up 0.09% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #218 holding.
  • Meiji Yasuda Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Meiji Yasuda Asset Management's Elevance Health position peaked at $3.35M in Q2 2019.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.